Company / Profit Margin
Tango Therapeutics, Inc. Profit Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-162.8%
FY2025
5-year range
-678.8% / -157.2%
FY2021-FY2025
Trend
+47.4%
vs FY2024
Sector context
#106 of 146
Health Care
What the data says
At -162.8%, Tango Therapeutics, Inc.'s profit margin ranks #106 of 146 in the Health Care sector. Profit Margin returned to growth in FY2025 after 2 years of decline, reaching -162.8%.
Based on SEC 10-K filings.
-162.8% in FY2025 with a 3-year CAGR of -5.6%.
Improved from -278.5% to -162.8% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -5.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#106 of 146 in Health CareTop 73% of 146This company -162.8% Sector average -796.3%
▼
+79.5% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 47.4% year-over-year.
- Currently 633.4pp above the Health Care sector average.
- Peak profit margin was recorded in FY2022.
- Lowest profit margin in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -162.8% | +47.4% |
| FY2024 | -309.7% | -11.2% |
| FY2023 | -278.5% | -77.2% |
| FY2022 | -157.2% | +76.8% |
| FY2021 | -678.8% | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026